172株奇异变形杆菌和68株普通变形杆菌临床分布及其耐药性
作者:
作者单位:

作者简介:

刘文恩

通讯作者:

中图分类号:

R378.2

基金项目:

湖南省教育厅湘教通(2012)594号


Clinical distribution and antimicrobial resistance of 172 Proteus mirabilis isolates and 68 Proteus vulgaris  isolates
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 文章评论
    摘要:

    目的对某院临床分离的奇异变形杆菌和普通变形杆菌进行分析,检测常用抗菌药物对其的体外活性,为临床合理使用抗菌药物提供依据。方法对该院2011年1月1日—2013年6月30日临床分离的172株奇异变形杆菌和68株普通变形杆菌进行分析,采用纸片扩散法进行药敏试验;WHONET 5.4软件进行数据分析。结果奇异变形杆菌标本主要来源为创面分泌物(26.74%)、痰液(22.68%)和尿液(18.61%);普通变形杆菌主要来源为创面分泌物(48.53%)、尿液(17.65%)和痰液(11.77%)。奇异变形杆菌对氨苄西林、复方磺胺甲口恶唑耐药率均>45.00%;普通变形杆菌对头孢唑林、复方磺胺甲口恶唑耐药率高,分别为86.76%、41.18%;奇异变形杆菌和普通变形杆菌对哌拉西林/他唑巴坦、头孢噻肟、头孢他啶、头孢吡肟、碳青霉烯类(厄他培南、美罗培南)、阿米卡星的耐药率均<20.00%。结论奇异变形杆菌和普通变形杆菌对于哌拉西林/他唑巴坦、头孢噻肟、头孢他啶、头孢吡肟、厄他培南、美罗培南、阿米卡星敏感率高,上述抗菌药物可作为临床治疗相关感染的经验用药。

    Abstract:

    ObjectiveTo analyze strains of Proteus mirabilis (P.mirabilis) and Proteus vulgaris (P. vulgaris) isolated in a hospital, detect resistance to commonly used antimicrobial agents,and provide reference for rational application of antimicrobial agents in clinic. Methods172 P.mirabilis isolates and 68 P. vulgaris isolates isolated between January 1, 2011 and June 30,2013 were analyzed,  antimicrobial  resistance susceptibility testing were performed by disk diffusion method,  data were analyzed with WHONET 5.4 software. ResultsP. mirabilis strains were mainly isolated from wound secretion(26.74%),sputum(22.68%)and urine(18.61%), P. vulgaris were mainly from wound secretion(48.53%),urine(17.65%)and sputum(11.77%). The resistance rates of P. mirabilis to ampicillin and trimethoprim/sulfamethoxazole were both>45.00%; the resistance rates of P. vulgaris to cefazolin and trimethoprim/sulfamethoxazole was 86.76% and 41.18% respectively;the resistance rates of P.mirabilis and  P. vulgaris to piperacillin/tazobactam, cefotaxime,ceftazidime, cefepime, carbapenems (ertapenem and meropenem) and amikacin were all <20.00%. ConclusionThe resistance rates of P.mirabilis and  P. vulgaris  to piperacillin/tazobactam, cefotaxime, ceftazidime, cefepime, ertapenem, meropenem and amikacin are all high, and can be used as the empirical medication for the treatment of related infection.

    参考文献
    相似文献
引用本文

罗珊,刘文恩,晏群,等.172株奇异变形杆菌和68株普通变形杆菌临床分布及其耐药性[J]. 中国感染控制杂志,2014,13(12):710-713. DOI:10.3969/j. issn.1671-9638.2014.12.002.
LUO Shan, LIU Wenen, YAN Qun, et al. Clinical distribution and antimicrobial resistance of 172 Proteus mirabilis isolates and 68 Proteus vulgaris  isolates[J]. Chin J Infect Control, 2014,13(12):710-713. DOI:10.3969/j. issn.1671-9638.2014.12.002.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2014-05-20
  • 最后修改日期:2014-07-22
  • 录用日期:
  • 在线发布日期: 2014-12-30
  • 出版日期: